Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 13132 Triple Negative Breast Neoplasms 1149 Neoplasms 749 Ovarian Neoplasms 680 Neoplasm Metastasis 590 Lung Neoplasms 582 Colorectal Neoplasms 580 Prostatic Neoplasms 560 Carcinoma, Non-Small-Cell Lung 535 Pancreatic Neoplasms 380 Melanoma 366 Stomach Neoplasms 350 Colonic Neoplasms 330 Motor Activity 285 Breast Neoplasms, Male 285 Carcinoma, Intraductal, Noninfiltrating 277 Uterine Cervical Neoplasms 267 Head and Neck Neoplasms 266 Endometrial Neoplasms 256 Carcinoma, Renal Cell 216 Sarcoma 203 Urinary Bladder Neoplasms 192 Squamous Cell Carcinoma of Head and Neck 192 Lymphedema 190 Esophageal Neoplasms 189 Breast Carcinoma In Situ 189 Brain Neoplasms 183 Fatigue 166 Carcinoma, Ovarian Epithelial 151 Small Cell Lung Carcinoma 148

Interventions

18-O-demethylcervinomycin A2 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

ER+HER2- Breast Cancer × Breast × Clear all

NCT07109284 2025-08-07

NeoSaciA

West China Hospital

Phase 2 Not yet recruiting

ER+HER2- Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡